AU2001284038A1 - Sgk2 and sgk3 used as diagnostic and therapeutic targets - Google Patents
Sgk2 and sgk3 used as diagnostic and therapeutic targetsInfo
- Publication number
- AU2001284038A1 AU2001284038A1 AU2001284038A AU2001284038A AU2001284038A1 AU 2001284038 A1 AU2001284038 A1 AU 2001284038A1 AU 2001284038 A AU2001284038 A AU 2001284038A AU 2001284038 A AU2001284038 A AU 2001284038A AU 2001284038 A1 AU2001284038 A1 AU 2001284038A1
- Authority
- AU
- Australia
- Prior art keywords
- sgk2
- sgk3
- diagnostic
- therapeutic targets
- targets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10042137.7 | 2000-08-28 | ||
DE10042137A DE10042137A1 (en) | 2000-08-28 | 2000-08-28 | sgk2 and sgk3 as diagnostic and therapeutic targets |
PCT/EP2001/009890 WO2002017893A2 (en) | 2000-08-28 | 2001-08-28 | Sgk2 and sgk3 used as diagnostic and therapeutic targets |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2001284038A1 true AU2001284038A1 (en) | 2002-06-06 |
AU2001284038B2 AU2001284038B2 (en) | 2007-03-22 |
Family
ID=7653998
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001284038A Ceased AU2001284038B2 (en) | 2000-08-28 | 2001-08-28 | Sgk2 and SGK3 used as diagnostic and therapeutic targets |
AU8403801A Pending AU8403801A (en) | 2000-08-28 | 2001-08-28 | Sgk2 and sgk3 used as diagnostic and therapeutic targets |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU8403801A Pending AU8403801A (en) | 2000-08-28 | 2001-08-28 | Sgk2 and sgk3 used as diagnostic and therapeutic targets |
Country Status (18)
Country | Link |
---|---|
US (1) | US20040038882A1 (en) |
EP (1) | EP1313476B1 (en) |
JP (1) | JP2004507493A (en) |
CN (1) | CN1193756C (en) |
AT (1) | ATE343386T1 (en) |
AU (2) | AU2001284038B2 (en) |
CA (1) | CA2419472A1 (en) |
CY (1) | CY1105942T1 (en) |
DE (2) | DE10042137A1 (en) |
DK (1) | DK1313476T3 (en) |
ES (1) | ES2275713T3 (en) |
HK (1) | HK1061801A1 (en) |
HU (1) | HUP0302938A3 (en) |
MX (1) | MXPA03001739A (en) |
PL (1) | PL359714A1 (en) |
PT (1) | PT1313476E (en) |
RU (1) | RU2310471C2 (en) |
WO (1) | WO2002017893A2 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10346913A1 (en) * | 2003-10-09 | 2005-05-04 | Merck Patent Gmbh | acylhydrazone |
RU2006135654A (en) * | 2004-03-11 | 2008-09-10 | Мерк Патент ГмбХ (DE) | METHODS FOR MODULATION OF GLUTAMATE RECEPTORS FOR TREATMENT OF NEUROPSYCHIATRIC DISORDERS, INCLUDING THE APPLICATION OF SERUM AND KLUCKORTICOID KINASE MODULATORS |
WO2005118832A2 (en) * | 2004-06-01 | 2005-12-15 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl) |
DE102007002717A1 (en) | 2007-01-18 | 2008-07-24 | Merck Patent Gmbh | Heterocyclic indazole derivatives |
DE102007022565A1 (en) | 2007-05-14 | 2008-11-20 | Merck Patent Gmbh | Heterocyclic indazole derivatives |
DE102008029072A1 (en) * | 2008-06-10 | 2009-12-17 | Lang, Florian, Prof. Dr.med. | Substance, which inhibits serum and glucocorticoid dependent kinase 3, useful for the prophylaxis and/or treatment or diagnosis of age-related diseases e.g. arteriosclerosis, skin atrophy, myasthenia, infertility, stroke and kyphosis |
DE102008038222A1 (en) | 2008-08-18 | 2010-02-25 | Merck Patent Gmbh | Indazol-5-carboxylic acid derivatives |
DE102008038221A1 (en) | 2008-08-18 | 2010-02-25 | Merck Patent Gmbh | 7-azaindole derivatives |
DE102008038220A1 (en) | 2008-08-18 | 2010-02-25 | Merck Patent Gmbh | oxadiazole |
EP2177510A1 (en) | 2008-10-17 | 2010-04-21 | Universität des Saarlandes | Allosteric protein kinase modulators |
DE102008059133A1 (en) | 2008-11-26 | 2010-05-27 | Merck Patent Gmbh | Difluorophenyl diacylhydrazide derivatives |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242397A (en) * | 1989-06-20 | 1993-09-07 | Cedars-Sinai Medical Center | Catheter device and method of use for intramural delivery of protein kinase C and tyrosine protein kinase inhibitors to prevent restenosis after balloon angioplasty |
US5385915A (en) * | 1990-05-16 | 1995-01-31 | The Rockefeller University | Treatment of amyloidosis associated with Alzheimer disease using modulators of protein phosphorylation |
US5137912A (en) * | 1991-01-28 | 1992-08-11 | National Science Council Of Republic Of China | Chelerythrine inhibits platelet aggregation--a potential anti-aggregation drug |
US5243397A (en) * | 1992-11-25 | 1993-09-07 | Elop-Electrooptics Industries Ltd. | Distance measuring system |
GB9325395D0 (en) * | 1993-12-11 | 1994-02-16 | Ciba Geigy Ag | Compositions |
US7625697B2 (en) * | 1994-06-17 | 2009-12-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for constructing subarrays and subarrays made thereby |
US6083920A (en) * | 1995-12-21 | 2000-07-04 | Ayurcore, Inc. | Compositions for modulating intracellular inositol trisphosphate concentration |
DE19708173A1 (en) * | 1997-02-28 | 1998-09-03 | Dade Behring Marburg Gmbh | Cell volume regulated human kinase h-sgk |
EP0887081B1 (en) * | 1997-06-27 | 2003-04-23 | Smithkline Beecham Corporation | Human serum glucocorticoid regulated kinase, a target for chronic renal disease and diabetic nephropathy |
EP0889127A1 (en) * | 1997-07-01 | 1999-01-07 | Smithkline Beecham Corporation | Serine/threonine protein kinase (H-SGK2) |
CO4940430A1 (en) * | 1997-07-07 | 2000-07-24 | Novartis Ag | POLYCLIC COMPOUNDS CONTAINING HYDROGENATED STAUROSPORIN WITH CONVENIENT PHARMACOLOGICAL PROPERTIES AND AN INHIBITING EFFECT ON THE GROWTH OF TUMOR CELLS |
CA2274776C (en) * | 1997-10-08 | 2008-11-25 | Noboru Kaneko | Method for analyzing annexin v in urine and use thereof |
US6162613A (en) * | 1998-02-18 | 2000-12-19 | Vertex Pharmaceuticals, Inc. | Methods for designing inhibitors of serine/threonine-kinases and tyrosine kinases |
WO1999061039A2 (en) * | 1998-05-22 | 1999-12-02 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Novel composition for modulating ischemic cell death |
DE19917990A1 (en) * | 1999-04-20 | 2000-11-02 | Florian Lang | Medicament containing inhibitors of cell volume regulated human kinase h-sgk |
ATE441107T1 (en) * | 2002-03-01 | 2009-09-15 | Siemens Healthcare Diagnostics | ASSAY FOR MONITORING CANCER PATIENTS BASED ON LEVELS OF THE EXTRACELLULAR DOMAIN (ECD) ANALYTE OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR), ALONE OR IN COMBINATION WITH OTHER ANALYTES, IN BODY FLUID SAMPLES |
-
2000
- 2000-08-28 DE DE10042137A patent/DE10042137A1/en not_active Withdrawn
-
2001
- 2001-08-28 PT PT01962975T patent/PT1313476E/en unknown
- 2001-08-28 MX MXPA03001739A patent/MXPA03001739A/en active IP Right Grant
- 2001-08-28 HU HU0302938A patent/HUP0302938A3/en unknown
- 2001-08-28 AT AT01962975T patent/ATE343386T1/en not_active IP Right Cessation
- 2001-08-28 AU AU2001284038A patent/AU2001284038B2/en not_active Ceased
- 2001-08-28 DE DE50111328T patent/DE50111328D1/en not_active Expired - Fee Related
- 2001-08-28 WO PCT/EP2001/009890 patent/WO2002017893A2/en active IP Right Grant
- 2001-08-28 JP JP2002522867A patent/JP2004507493A/en not_active Withdrawn
- 2001-08-28 AU AU8403801A patent/AU8403801A/en active Pending
- 2001-08-28 PL PL01359714A patent/PL359714A1/en not_active Application Discontinuation
- 2001-08-28 RU RU2003107920/15A patent/RU2310471C2/en not_active IP Right Cessation
- 2001-08-28 US US10/362,930 patent/US20040038882A1/en not_active Abandoned
- 2001-08-28 ES ES01962975T patent/ES2275713T3/en not_active Expired - Lifetime
- 2001-08-28 EP EP01962975A patent/EP1313476B1/en not_active Expired - Lifetime
- 2001-08-28 CN CNB018163351A patent/CN1193756C/en not_active Expired - Fee Related
- 2001-08-28 CA CA002419472A patent/CA2419472A1/en not_active Abandoned
- 2001-08-28 DK DK01962975T patent/DK1313476T3/en active
-
2004
- 2004-07-05 HK HK04104810A patent/HK1061801A1/en not_active IP Right Cessation
-
2007
- 2007-01-22 CY CY20071100078T patent/CY1105942T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001264297A1 (en) | Microcontactor probe and electric probe unit | |
AU2001257127A1 (en) | Inhibition of abnormal cell proliferation with camptothecin and combinations including the same | |
AU2001264313A1 (en) | Pyrazolopyridine compounds and use thereof as drugs | |
AU2002218026A1 (en) | Cardiovascular disease diagnostic and therapeutic targets | |
AU4853701A (en) | Medical combinations comprising tiotropium and budesonide | |
AU2001244355A1 (en) | Heterobiarylsulphonamides and their use as pde 7 inhibitors | |
AUPQ886100A0 (en) | Diagnostic test | |
AU1425801A (en) | Field test chamber arrangement | |
AU2001248214A1 (en) | Device for the introduction of medical items | |
AU2001295322A1 (en) | Skin testing device | |
AU1732101A (en) | Game device | |
AU7377200A (en) | Combination therapy including camptothecin | |
AUPQ155799A0 (en) | Therapeutic methods and uses | |
AU2001284038A1 (en) | Sgk2 and sgk3 used as diagnostic and therapeutic targets | |
HUP0302938A3 (en) | Sgk2 and sgk3 used as diagnostic and therapeutic targets | |
AU2001255730A1 (en) | Methods and compositions for the treatment of cardiac indications | |
AU1955201A (en) | Insecticide targets and methods of use | |
AU6835300A (en) | Diagnostic kit and use thereof | |
AU2001274172A1 (en) | Novel needle for medical device and device comprising same | |
AU2001252671A1 (en) | Pyridobenzodiazine derivatives and processes for the preparation thereof | |
AUPR186000A0 (en) | Elapsed time indicator | |
AU3570900A (en) | Arrangement and procedure for testing and improving the physical condition and technical skill of sportsmen | |
AU2001215965A1 (en) | Retrofit patch and/or test panel | |
AU6262601A (en) | Phospholipase d effectors for therapy and screening | |
AU2001252235A1 (en) | A composition comprising camptothecin or a camptothecin derivative and an alkylating agent for the treatment of cancer |